This topic contains a solution. Click here to go to the answer

Author Question: A client with a history of suicidal behavior and schizophrenia stopped taking clozapine (Clozaril) ... (Read 71 times)

Collmarie

  • Hero Member
  • *****
  • Posts: 569
A client with a history of suicidal behavior and schizophrenia stopped taking clozapine (Clozaril) after four weeks of therapy.
 
  The client is currently experiencing a return of hallucinations. What might the nurse assess when determining the reason the client stopped taking the medication?
  Standard Text: Select all that apply.
  1. Feeling sedated all the time
  2. Significant weight gain
  3. Agitation
  4. Fatigue and headache
  5. Lack of desire to consume alcohol

Question 2

A client prescribed haloperidol (Haldol) is not demonstrating an improvement of psychotic behavior after taking the medication for 5 days. The nurse would anticipate which dose change for the medication?
 
  1. No changes are necessary, as it might take 24 weeks for significant improvement to be noted.
  2. The dose of Haldol might be increased.
  3. The order for Haldol might be discontinued.
  4. Xanax might be added to improve the symptoms of psychotic behavior.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Pamela.irrgang@yahoo.com

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

Correct Answer: 1,2,3,4
Rationale 1: Clients do not like the side effect of being sedated all the time.
Rationale 2: Substantial weight gain has been reported in some clients taking this medication. This is a reason some stop taking the medication.
Rationale 3: Agitation may be an extrapyramidal symptom of treatment with this medication and is an unwanted adverse effect.
Rationale 4: Fatigue and headache are possible side effects of this medication.
Rationale 5: The desire to drink alcohol would be a reason for the client to stop taking this medication.
Global Rationale: Clients do not like the side effect of being sedated all the time. Substantial weight gain has been reported in some clients taking this medication. This is a reason some stop taking the medication. Agitation may be an extrapyramidal symptom of treatment with this medication and is an unwanted adverse effect. Fatigue and headache are possible side effects of this medication. The desire to drink alcohol would be a reason for the client to stop taking this medication.

Answer to Question 2

Correct Answer: 1
Rationale 1: The pharmacotherapy of psychosis is a long-term process, with symptoms resolving gradually. It could take 24 weeks before a significant change in behavior is noted.
Rationale 2: Haldol is a high-potency drug that controls symptoms in small doses. Increasing the dose would cause severe side effects.
Rationale 3: The Haldol has not been taken long enough to warrant discontinuation, and there is no information indicating that it should be discontinued due to side effects.
Rationale 4: The addition of a benzodiazepine would cause added CNS depression.
Global Rationale: The pharmacotherapy of psychosis is a long-term process, with symptoms resolving gradually. It could take 24 weeks before a significant change in behavior is noted. Haldol is a high-potency drug that controls symptoms in small doses. Increasing the dose would cause severe side effects. The Haldol has not been taken long enough to warrant discontinuation, and there is no information indicating that it should be discontinued due to side effects. The addition of a benzodiazepine would cause added CNS depression.




Collmarie

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


pratush dev

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library